The insulin-sensitizing, anti-diabetic, anti-atherogenic, and anti-inflammatory properties of adiponectin suggest its potential relevance as a therapeutic target for diabetes and metabolic syndrome[34]. The gene discussed is ADIPOQ; the disease is metabolic syndrome.